Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease
Authors:
- P ValagussaPVP Valagussa
- A SantoroASA Santoro
- F Fossati BellaniFBF Fossati Bellani
- F FranchiFFF Franchi
- A BanfiABA Banfi
- G BonadonnaGBG Bonadonna
Open Access
- 1 March 1982
- journal article
- Published by American Society of Hematology in Blood
- Vol. 59 (3) , 488-494
Abstract
One of the most serious complications of successful treatments for Hodgkin's disease is an increased incidence of acute nonlymphocytic leukemia (ANLL) and other malignancies. A retrospective analysis carried out on 1032 consecutive patients with Hodgkin's disease admitted to our Institute between 1965 and 1978 and treated with radiotherapy (RT) or chemotherapy or both modalities revealed that within 10 yr from initial therapy. ANLL was documented in 3% of patients, and over a comparable period of time 7.9% of patients developed other malignancies. ANLL was observed only in patients treated with chemotherapeutic regimens containing alkylating agents and/or procarbazine either alone (2.3%) or associated with RT (4%). Other second tumors were documented in patients given RT with or without chemotherapy. No second malignancies were observed in patients given ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine) with or without RT. The incidence of ANLL was higher in patients given chemotherapy as salvage treatment upon relapse following primary irradiation (6.1%) compared to patients initially treated with combined modality (1.5%). The difference, however, failed to reach statistical significance. Since our analysis supports the evidence of a major role played by alkylating agents, procarbazine, and RT in inducing second malignancies, regimens not containing there drugs or their administration through treatments of different intensity warrant careful consideration.Keywords
This publication has 11 references indexed in Scilit:
- ABVD chemotherapy in the treatment of Hodgkin's diseaseCancer Treatment Reviews, 1982
- Evolution in The Treatment Strategy of Hodgkin'S Disease1982
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- Second malignancy in patients treated for Hodgkin's diseaseCancer, 1980
- Acute nonlymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-hodgkin's lymphoma and chronic lymphocytic leukemia: Clinical studiesCancer, 1979
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Combined modality treatment of Hodgkin's disease confined to lymph nodesThe American Journal of Medicine, 1979
- Acute Leukemia Following Prolonged Cytotoxic Agent TherapyMedicine, 1979
- Toxicity of Antineoplastic Agents in Man: Chromosomal Aberrations, Antifertility Effects, Congenital Malformations, and Carcinogenic Potential1976
- The Incidence of Multiple Primary Cancers. I. Development of Further Cancers in Patients With Lymphomas, Leukemias, and MyelomaJNCI: Journal of the National Cancer Institute, 1967